MED14
Mediator of RNA polymerase II transcription subunit 14
[_nghost-pharos-c3723733598]{display:flex;flex-direction:column;align-items:center;position:absolute;margin-top:70px;z-index:100000;width:100%}.pharos-alert[_ngcontent-pharos-c3723733598]{display:flex;justify-content:space-between}.alert[_ngcontent-pharos-c3723733598]{padding:15px;border:1px solid transparent;border-radius:4px;width:60%;align-items:center}.alert-success[_ngcontent-pharos-c3723733598]{color:#000;background-color:#6fe6a4}.alert-info[_ngcontent-pharos-c3723733598]{color:#000;background-color:#5bc0de}.alert-warning[_ngcontent-pharos-c3723733598]{color:#000;background-color:#ffb259}.alert-danger[_ngcontent-pharos-c3723733598]{color:#000;background-color:#f44336}.devmessage[_ngcontent-pharos-c3723733598]{font-size:small;opacity:.75;padding-left:15px;display:block}.disabled-icon[_ngcontent-pharos-c2749090960]{color:#000!important;opacity:.2}.exploreLink[_ngcontent-pharos-c2749090960]{display:flex;justify-content:flex-end}.centered[_ngcontent-pharos-c2749090960]{display:flex;justify-content:center;padding-top:2px;padding-bottom:2px}.tdl-progress[_ngcontent-pharos-c2749090960]{margin-bottom:1vh}.row[_ngcontent-pharos-c2749090960], .explanation[_ngcontent-pharos-c2749090960], .centered[_ngcontent-pharos-c2749090960]{width:100%}.mat-icon[_ngcontent-pharos-c2749090960]{padding-right:7px}.mat-slider-thumb-label[_ngcontent-pharos-c2749090960]{transform:rotate(45deg)!important;border-radius:50% 50% 0!important}.mat-slider-thumb[_ngcontent-pharos-c2749090960]{transform:scale(0)!important}.mat-slider-thumb-label-text[_ngcontent-pharos-c2749090960]{opacity:1!important}.exploreButton[_ngcontent-pharos-c2749090960]{padding-top:10px}
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
hub protein | 0.98 | ||
virus perturbation | 0.94 | ||
interacting protein | 0.91 | ||
kinase perturbation | 0.84 | ||
disease perturbation | 0.83 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions